Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Pernilla Hansdotter Andersson"'
Autor:
Peter Scherman, Pernilla Hansdotter, Erik Holmberg, Frank Viborg Mortensen, Sune H. Petersen, Magnus Rizell, Peter Naredi, Ingvar Syk, Peer Wille-Jørgensen, Erzsébet Horváth-Puhó, Søren Laurberg, Lars Påhlman, Andrew Renehan, Kenneth Smedh, Henrik Christensen, Jesper Dan Nielsen, Per Jess, Allan Gorm Pedersen, Mogens Rørbæk Madsen, Per Vadgaard Andersen, Erling Østergaard, Pernilla Hansdotter Andersson, Jonas Bengtsson, Mats Bragmark, Pamela Buchwald, Monika Egenvall, Parastau Farahnak, Joakim Folkesson, Michael Goldinger, Rolf Heuman, Kenneth Lindberg, Anna Martling, Pia Näsvall, Johan Ottosson, Birger Sandzén, Carlos Barberousse
Publikováno v:
Scherman, P, Hansdotter, P, Holmberg, E, Viborg Mortensen, F, Petersen, S H, Rizell, M, Naredi, P, Syk, I & COLOFOL Study Group 2023, ' High resection rates of colorectal liver metastases after standardized follow-up and multimodal management : an outcome study within the COLOFOL trial ', HPB, vol. 25, no. 7, pp. 766-774 . https://doi.org/10.1016/j.hpb.2023.03.003
Scherman, P, Hansdotter, P, Holmberg, E, Viborg Mortensen, F, Petersen, S H, Rizell, M, Naredi, P, Syk, I, COLOFOL study group & Nielsen, J D 2023, ' High resection rates of colorectal liver metastases after standardized follow-up and multimodal management : an outcome study within the COLOFOL trial ', H P B . https://doi.org/10.1016/j.hpb.2023.03.003
Scherman, P, Hansdotter, P, Holmberg, E, Viborg Mortensen, F, Petersen, S H, Rizell, M, Naredi, P, Syk, I, COLOFOL study group & Nielsen, J D 2023, ' High resection rates of colorectal liver metastases after standardized follow-up and multimodal management : an outcome study within the COLOFOL trial ', H P B, vol. 25, no. 7, pp. 766-774 . https://doi.org/10.1016/j.hpb.2023.03.003
Scherman, P, Hansdotter, P, Holmberg, E, Viborg Mortensen, F, Petersen, S H, Rizell, M, Naredi, P, Syk, I, COLOFOL study group & Nielsen, J D 2023, ' High resection rates of colorectal liver metastases after standardized follow-up and multimodal management : an outcome study within the COLOFOL trial ', H P B . https://doi.org/10.1016/j.hpb.2023.03.003
Scherman, P, Hansdotter, P, Holmberg, E, Viborg Mortensen, F, Petersen, S H, Rizell, M, Naredi, P, Syk, I, COLOFOL study group & Nielsen, J D 2023, ' High resection rates of colorectal liver metastases after standardized follow-up and multimodal management : an outcome study within the COLOFOL trial ', H P B, vol. 25, no. 7, pp. 766-774 . https://doi.org/10.1016/j.hpb.2023.03.003
Background: Outcome after colorectal liver metastases (CRLM) resection has improved over time, despite increased resection rates. Hence, it's crucial to identify all patients possible to treat with curative intent. The objectives of this study were t
Autor:
Monika Egenvall, Anna Martling, Katalin Veres, Erzsébet Horváth-Puhó, Peer Wille-Jørgensen, Sune Høirup Petersen, Søren Laurberg, Henrik Toft Sørensen, Ingvar Syk, Per Vadgaard Andersen, Henrik Christensen, Jesper Dan Nielsen, Per Jess, Mogens Rørbæk Madsen, Allan Gorm Pedersen, Erling Østergaard, Pernilla Hansdotter Andersson, Jonas Bengtsson, Mats Bragmark, Pamela Buchwald, Parastau Farahnak, Joakim Folkesson, Lars Påhlman, Michael Goldinger, Rolf Heuman, Kenneth Lindberg, Pia Näsvall, Johan Ottosson, Birger Sandzén, Carlos Barberousse, Andrew Renehan, Kenneth Smedh
Publikováno v:
Egenvall, M, Martling, A, Veres, K, Horváth-Puhó, E, Wille-Jørgensen, P, Høirup Petersen, S, Laurberg, S, Sørensen, H T, Syk, I, Nielsen, J D & The COLOFOL Study Group 2021, ' No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels – An analysis within the COLOFOL randomized clinical trial ', European Journal of Surgical Oncology, vol. 47, no. 8, pp. 2053-2059 . https://doi.org/10.1016/j.ejso.2021.03.235
Egenvall, M, Martling, A, Veres, K, Horváth-Puhó, E, Wille-Jørgensen, P, Høirup Petersen, S, Laurberg, S, Sørensen, H T, Syk, I & The COLOFOL Study Group 2021, ' No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels – An analysis within the COLOFOL randomized clinical trial ', European Journal of Surgical Oncology, vol. 47, no. 8, pp. 2053-2059 . https://doi.org/10.1016/j.ejso.2021.03.235
Egenvall, M, Martling, A, Veres, K, Horváth-Puhó, E, Wille-Jørgensen, P, Høirup Petersen, S, Laurberg, S, Sørensen, H T, Syk, I, The COLOFOL Study Group, Andersen, P V, Christensen, H & Nielsen, J D 2021, ' No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels – An analysis within the COLOFOL randomized clinical trial ', European Journal of Surgical Oncology, vol. 47, no. 8, pp. 2053-2059 . https://doi.org/10.1016/j.ejso.2021.03.235
Egenvall, M, Martling, A, Veres, K, Horváth-Puhó, E, Wille-Jørgensen, P, Høirup Petersen, S, Laurberg, S, Sørensen, H T, Syk, I & The COLOFOL Study Group 2021, ' No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels – An analysis within the COLOFOL randomized clinical trial ', European Journal of Surgical Oncology, vol. 47, no. 8, pp. 2053-2059 . https://doi.org/10.1016/j.ejso.2021.03.235
Egenvall, M, Martling, A, Veres, K, Horváth-Puhó, E, Wille-Jørgensen, P, Høirup Petersen, S, Laurberg, S, Sørensen, H T, Syk, I, The COLOFOL Study Group, Andersen, P V, Christensen, H & Nielsen, J D 2021, ' No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels – An analysis within the COLOFOL randomized clinical trial ', European Journal of Surgical Oncology, vol. 47, no. 8, pp. 2053-2059 . https://doi.org/10.1016/j.ejso.2021.03.235
Background Patients with colorectal cancer were examined to determine (1) whether elevated carcinoembryonic antigen (CEA) levels, either before treatment or after surgery, was associated with an increased risk of overall or colorectal cancer-specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d749820160b77146ec4eaf2f9a7247d
https://vbn.aau.dk/ws/files/517893594/1_s2.0_S0748798321003772_main.pdf
https://vbn.aau.dk/ws/files/517893594/1_s2.0_S0748798321003772_main.pdf
Autor:
Pernilla Hansdotter Andersson, Erzsébet Horváth-Puhó, Ingvar Syk, Henrik Toft Sørensen, Anna Martling, Peer Wille-Jørgensen, Sune Høirup Petersen
Publikováno v:
Clinical Epidemiology
Hansdotter Andersson, P, Wille-Jørgensen, P, Horváth-Puhó, E, Petersen, S H, Martling, A, Sørensen, H T & Syk, I 2016, ' The COLOFOL trial : study design and comparison of the study population with the source cancer population ', Clinical epidemiology, vol. 8, pp. 15-21 . https://doi.org/10.2147/CLEP.S92661
Hansdotter Andersson, P, Wille-Jørgensen, P, Horváth-Puhó, E, Petersen, S H, Martling, A, Sørensen, H T & Syk, I 2016, ' The COLOFOL trial : study design and comparison of the study population with the source cancer population ', Clinical epidemiology, vol. 8, pp. 15-21 . https://doi.org/10.2147/CLEP.S92661
Pernilla Hansdotter Andersson,1 Peer Wille-Jørgensen,2 Erzsébet Horváth-Puhó,3 Sune Høirup Petersen,2 Anna Martling,4 Henrik Toft Sørensen,3 Ingvar Syk1 On behalf of the COLOFOL Study Group 1Department of Surgery, Skåne University Hospital, Ma